Page last updated: 2024-11-11

9-hydroxy-10,12,15-octadecatrienoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9-hydroxy-10,12,15-octadecatrienoic acid: structure given in first source; RN given refers to (S-(E,Z,Z))-isomer; cpd without isomeric designation not avail 1/90 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

9(S)-HOTrE : A 9-HOTrE consisting of (10E,12Z,15Z)-octadecatrienoic acid in which the 9-hydroxy group has S-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6439873
CHEBI ID80447
SCHEMBL ID8263230
MeSH IDM0172107

Synonyms (26)

Synonym
9s-hydroxy-10e,12z,15z-octadecatrienoic acid
9s-hotre
LMFA02000024
(9s)-(10e,12z,15z)-9-hydroxyoctadecatri-10,12,15-enoic acid
9(s)-hot
9(s)-hotre
(9s,10e,12z,15z)-9-hydroxyoctadeca-10,12,15-trienoic acid
10-12-15-octadecatrienoic acid, 9-hydroxy-, (s-(e,z,z))-
9-hydroxy-10,12,15-octadecatrienoic acid
9-oh-10,12,15-odta
(10e,12z,15z)-9-oh-10,12,15-odta
89886-42-0
(9s,10e,12z,15z)-9-hydroxyoctadecatrienoic acid
CHEBI:80447
SCHEMBL8263230
10,12,15-octadecatrienoic acid, 9-hydroxy-, (9s,10e,12z,15z)-
RIGGEAZDTKMXSI-MEBVTJQTSA-N
10,12,15-octadecatrienoicacid,9-hydroxy-,(9s,10e,12z,15z)-
Q27149496
9(s)-hydroxy-10e,12z,15z-octadecatrienoic acid
sr-01000946951
SR-01000946951-1
9(s)-hydroxy-10(e),12(z),15(z)-octadecatrienoic acid
PD020943
DTXSID601345732
AKOS040756087
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
9-HOTrEA hydroxyoctadecatrienoic acid that consists of 10E,12Z,15Z-octadecatrienoic acid bearing an additional 9-hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.69 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]